Diethylene Glycol Dibutanoate

Diethylene Glycol Dibutanoate

SCHEMBL421383

CCCC(=O)OCCOCCOC(=O)CCC

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.58
ALDH1A1 P00352 4/20 0.52
TSHR P16473 3/20 0.44
ADRA2A P08913 1/20 0.44
ADRA1A P35348 1/20 0.44
MAPT P10636 1/20 0.43
BLM P54132 1/20 0.43
DNM1 Q05193 1/20 0.42
NAAA Q02083 1/20 0.41
HTR2C P28335 1/20 0.41
EPHX2 P34913 2/20 0.41
TP53 P04637 2/20 0.39
HIF1A Q16665 2/20 0.39
HSD17B10 Q99714 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
THRB P10828 1/20 0.39
PAM P19021 2/20 0.38
FFAR3 O14843 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13465983 1.00 DGKA (0.58) DGKAALDH1A1TSHRADRA2AADRA1A
SCHEMBL29601907 1.00 DGKA (0.58) DGKAALDH1A1TSHRADRA2AADRA1A
Triethylene Glycol Dibutanoate SCHEMBL4305344 1.00 DGKA (0.58) DGKAALDH1A1TSHRADRA2AADRA1A
SCHEMBL29253805 0.95 DGKA (0.54) DGKAALDH1A1TSHRADRA2AADRA1A
SCHEMBL2249107 0.95 DGKA (0.54) DGKAALDH1A1TSHRADRA2AADRA1A
SCHEMBL181434 0.93 ALDH1A1 (0.56) DGKAALDH1A1TSHRADRA2AADRA1A
SCHEMBL181703 0.93 ALDH1A1 (0.52) DGKAALDH1A1TSHRADRA2AADRA1A
SCHEMBL420321 0.93 ALDH1A1 (0.52) DGKAALDH1A1TSHRADRA2AADRA1A
Ethylene Glycol Dibutanoate SCHEMBL104207 0.92 DGKA (0.65) DGKAALDH1A1TSHRADRA2AADRA1A
SCHEMBL1362180 0.91 DGKA (0.50) DGKAALDH1A1TSHRADRA2AADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250293303-A1 SECONDARY BATTERY MURATA MANUFACTURING CO., LTD. (JP) 2025-09-18 US disclosed
WO-2024195303-A1 SECONDARY BATTERY 株式会社村田製作所 2024-09-26 WO disclosed
CN-118344798-A Aqueous 2K coating composition 巴斯夫涂料有限公司 2024-07-16 CN disclosed
CN-115461412-B Organopolysiloxane-containing composition, method for producing same, coating agent, and coated article 信越化学工业株式会社 2024-05-31 CN disclosed
CN-117983518-A Method for manufacturing laminated structure and use thereof 株式会社钟化 2024-05-07 CN disclosed
US-20230137990-A1 COMPOSITION CONTAINING ORGANOPOLYSILOXANE, PRODUCTION METHOD THEREFOR, COATING MATERIAL, AND COATED ARTICLE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-05-04 US disclosed
EP-4141049-A1 COMPOSITION CONTAINING ORGANOPOLYSILOXANE, PRODUCTION METHOD THEREFOR, COATING MATERIAL, AND COATED ARTICLE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-03-01 EP disclosed
CN-107880545-B Resin composition, method for producing cured product, and cured product 东京应化工业株式会社 2022-03-18 CN disclosed
US-9912012-B2 Secondary battery, battery pack, electric vehicle, energy storage system, electric power tool, and electronic unit MURATA MANUFACTURING CO., LTD. (JP) 2018-03-06 US disclosed
US-20180048026-A1 SECONDARY BATTERY, ELECTROLYTIC SOLUTION, BATTERY PACK, ELECTRONIC DEVICE, AND ELECTRICAL VEHICLE TOHOKU MURATA MANUFACTURING CO., LTD. (JP) 2018-02-15 US disclosed
US-20080254237-A1 Polymer Film, and Optically-Compensatory Film, Polarizer and Liquid-Crystal Display Device Comprising the Same FUJIFILM CORPORATION (JP) 2008-10-16 US disclosed
US-20080242626-A1 End-Modified Poly(beta-amino esters) and Uses Thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2008-10-02 US disclosed
US-7427394-B2 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2008-09-23 US disclosed
US-20080145338-A1 Acrylate-terminated poly(beta-amino esters); high throughput assay; biocompatability NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-06-19 US disclosed
US-20080062357-A1 CYCLIC OLEFIN RESIN FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2008-03-13 US disclosed
US-20080043177-A1 Liquid Crystal Display Device FUJIFILM CORPORATION (JP) 2008-02-21 US disclosed
US-20070292635-A1 Optical Compensation Polarizing Plate, Image Display Unit and Liquid Crystal Display Unit FUJIFILM CORPORATION (JP) 2007-12-20 US disclosed
US-20070285603-A1 Transparent Film And Optical Compensatory Film, Polarizing Plate And Liquid-Crystal Display Device Employing It FUJI PHOTO FILM CO., LTD. (JP) 2007-12-13 US disclosed
US-20070259134-A1 Cellulose Compound Film, Optical Compensation Sheet, Polarizing Plate, and Liquid Crystal Display Device FUJIFILM CORPORATION (JP) 2007-11-08 US disclosed
US-20070059458-A1 Cellulose acylate film, optically compensatory film, polarizing plate and liquid crystal display FUJI PHOTO FILM CO., LTD. (JP) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080145338-A1 Acrylate-terminated poly(beta-amino esters); high throughput assay; biocompatability ACP1, ILK, BCAT2 DGKA 2497/4885ALDH1A1 891/4885TSHR 4541/4885
US-20080242626-A1 End-Modified Poly(beta-amino esters) and Uses Thereof PARN, PARG, POLL DGKA 1844/4885ALDH1A1 2664/4885TSHR 4517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.